GALAPAGOS NV News

6-K: Report of foreign private issuer (related to financial reporting)

SECAug 2 16:06 ET · Announcements

Retail Investors Are Galapagos NV's (AMS:GLPG) Biggest Owners and Were Hit After Market Cap Dropped €74m

Yahoo FinanceJun 14 00:23 ET

Express News | Galapagos NV-Granted Option to Exclusively License Uza-Cel for Global Development,Commercialization in Potential Future Solid Tumor Cancer Indications

ReutersMay 30 16:02 ET

Express News | Galapagos NV: Galapagos Has Been Granted an Option to Exclusively License Uza-Cel for Global Development and Commercialization in Head & Neck Cancer

ReutersMay 30 16:01 ET

Express News | Galapagos NV: Adaptimmune to Receive Additional Development and Sales Milestone Payments of up to a Maximum of $465 Mln

ReutersMay 30 16:01 ET

Express News | Galapagos NV: Adaptimmune to Receive Initial Payments of $100 Mln

ReutersMay 30 16:01 ET

Galapagos NV Unveils New Employee Incentive Plans

TipRanksMay 17 12:08 ET

Galapagos NV Unveils Employee Subscription Plans

TipRanksMay 16 17:30 ET

Galapagos NV Expands U.S. CAR-T Therapy Production

TipRanksMay 16 09:29 ET

Express News | Galapagos NV : RBC Cuts Target Price to $35 From $38

ReutersMay 6 01:51 ET

Galapagos First Quarter 2024 Earnings: EPS: €0.36 (Vs €0.35 in 1Q 2023)

Yahoo FinanceMay 4 02:14 ET

Galapagos NV Reports Strong Q1 2024 Financials

TipRanksMay 3 11:28 ET

Galapagos NV Shareholders Approve Key Resolutions

TipRanksMay 1 07:30 ET

Galapagos NV Unveils CAR-T Therapy Advances

TipRanksApr 8 10:27 ET

Galapagos Showcases Innovative Approach in Hematological Cancer Care With Clinical and Translational Data Presentations at EBMT Congress 2024

Yahoo FinanceApr 4 16:01 ET